Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Understanding the Long-term Implications of Treatment of Rare Brain Tumours on Health-related Quality of Life: A European Cross-sectional Study

NCT04708548 is registered in ClinicalTrials.gov with Galina Velikova as lead sponsor.

NCT NCT04708548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04708548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Understanding the Long-term Implications of Treatment of Rare Brain Tumours on Health-related Quality of Life: A European Cross-sectional Study
Lead sponsor
Galina Velikova
Phase
Observational
Overall status
Completed
Start date
May 29, 2020
Completion date
February 28, 2023
Enrollment
267 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, health-related quality of life, long-term effects of cancer treatment, quality of life, who grade ii oligodendroglial tumor, who grade iii oligodendroglial tumor